| 摘要 |
<p>H:,/amcnovce/NRPortbI/DCC/AMC/5948I7I I.doc-I5/)1/2014 The present invention provides a peptide comprising a core residue sequence derivable from human FVIII which peptide is capable of binding to an MHC class II molecule without further antigen processing. The present invention also relates to the use of such peptides for the prevention or suppression of inhibitor antibody formation in haemophilia A and/or acquired haemophilia.</p> |
